TFF Pharmaceuticals, Inc. TFFP
Set alert
0.07 0.00 0.00%
At close · Dec 12
0.0611 Day range 0.0902
52-week range unavailable
- Open
- 0.0902
- Prev close
- 0.065
- Mkt cap
- 288.80K
- Vol
- 11.02M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0611
- High
- 0.0902
- Forward P/E
- -0.02
- Beta
- 1.32
- Short ratio
- 1.77
- Inst. own
- 24.37%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.15
- 200-d avg
- 2.39
- 1y target
- 0.00
Financial health
Altman Z-Score
-34.60 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2016 5y median -3.1× FY 2023
P/S 17.1×
FY 2016 5y median 0.0× FY 2023
P/B 1.3×
FY 2016 5y median 1.4× FY 2023
P/FCF -0.8×
FY 2016 5y median -3.3× FY 2023
EV/EBITDA -0.3×
FY 2016 5y median -0.7× FY 2023
EV/Sales 9.8×
FY 2016 5y median 0.0× FY 2023
FCF Yield -128.2%
FY 2016 5y median -30.4% FY 2023
Profitability
Gross Margin 31.5%
FY 2016 5y median 0.0% FY 2023
Operating Margin -2983.4%
FY 2016 5y median 0.0% FY 2023
Net Margin -2894.7%
FY 2016 5y median 0.0% FY 2023
ROE -222.0%
FY 2016 5y median -80.0% FY 2023
ROIC -226.1%
FY 2016 5y median -82.1% FY 2023
ROA -176.6%
FY 2016 5y median -76.1% FY 2023
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2023
Operating Income 31.1%
FY 2016 FY 2023
EPS (diluted) 55.3%
FY 2016 FY 2023
Free Cash Flow 44.2%
FY 2016 FY 2023
Financial Health
Current Ratio 3.1×
FY 2016 5y median 19.8× FY 2023
Quick Ratio 3.1×
FY 2016 5y median 19.8× FY 2023
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2023
Net Debt / EBITDA 0.3×
FY 2016 5y median 1.1× FY 2023
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2023
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31